Humanlinker company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Seed VC | Alive

Total Raised


Last Raised

$2.71M | 1 mo ago

About Humanlinker

Humanlinker develops artificial intelligence (AI) guided selling technology designed for enterprise sales teams. The company provides desktop applications, and hyper-targeted segmentation builders allowing AI algorithms to identify strategic accounts, enabling the customer future of enterprise sales. Humanlinker was founded in 2020 and is based in Montpellier, France.

Humanlinker Headquarter Location

450 Rue Baden Powell

Montpellier, 34000,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Humanlinker News

Humanlinker raises €2.5M to shape the future of revenue generation

Apr 12, 2022

Specialists in AI team management and revenue generation, Humanlinker has raised €2.5M from Karista (via the Paris Region Venture Fund), Founders Ventures and Business Angels. The start-up's goal is to strengthen its existing teams while spurring technological development, so that its desktop application can go to work for sales teams throughout Europe. ‍ ‍ Founded in 2020 in Montpellier and also based in Paris, Humanlinker is a RevTech Start-up developing a wonderful desktop application allowin

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.